Penserra Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-605
| Closed | -$28K | – | 1366 |
|
|
2021
Q3 | $28K | Buy |
605
+5
| +0.8% | +$231 | ﹤0.01% | 1193 |
|
|
2021
Q2 | $20K | Buy |
600
+20
| +3% | +$667 | ﹤0.01% | 1143 |
|
|
2021
Q1 | $23K | Buy |
580
+20
| +4% | +$793 | ﹤0.01% | 948 |
|
|
2020
Q4 | $24K | Buy |
+560
| New | +$24K | ﹤0.01% | 825 |
|
|
2017
Q2 | – | Sell |
-1,941
| Closed | -$15K | – | 524 |
|
|
2017
Q1 | $15K | Buy |
1,941
+832
| +75% | +$6.43K | ﹤0.01% | 406 |
|
|
2016
Q4 | $16K | Buy |
1,109
+478
| +76% | +$6.9K | ﹤0.01% | 714 |
|
|
2016
Q3 | $10K | Buy |
631
+158
| +33% | +$2.5K | ﹤0.01% | 796 |
|
|
2016
Q2 | $15K | Sell |
473
-2
| -0.4% | -$63 | ﹤0.01% | 503 |
|
|
2016
Q1 | $12 | Buy |
475
+158
| +50% | +$4 | ﹤0.01% | 501 |
|
|
2015
Q4 | $14K | Buy |
+317
| New | +$14K | ﹤0.01% | 457 |
|